Five-year follow-up of patients with difficult-to-treat rheumatoid arthritis

被引:3
|
作者
Takanashi, Satoshi [1 ]
Takeuchi, Tsutomu [1 ,2 ]
Kaneko, Yuko [1 ]
机构
[1] Keio Univ, Dept Internal Med, Div Rheumatol, Sch Med, 35 Shinanomachi,Shinjuku Ku, Tokyo 1608582, Japan
[2] Saitama Med Univ, Saitama, Japan
关键词
rheumatoid arthritis; difficult-to-treat rheumatoid arthritis (D2T RA); JAK inhibitors; interleukin-6 (IL-6); comorbidity; HAQ-DI; glucocorticoid; outcomes; prognosis; TOCILIZUMAB;
D O I
10.1093/rheumatology/keae325
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To elucidate the long-term outcomes of patients with difficult-to-treat rheumatoid arthritis (D2T RA).Methods We collected data on the clinical course of patients who had been identified as D2T RA in 2018 until 2023. We stratified the patients according to outcomes at the last visit: resolved D2T RA, persistent D2T RA and mortality. We compared their clinical characteristics and investigated the predictive factors for the resolution of D2T RA or mortality. Furthermore, we investigated the impact of the causes of D2T RA identified in 2018, multidrug resistance, comorbidities and socioeconomic factors on outcomes in 2023.Results Of 173 patients identified as D2T RA in 2018, 150 were included in the analysis. Among them, D2T RA was resolved in 67 (45%), 75 (50%) remained as D2T RA, and 8 (5%) died. Patients with resolved D2T RA were significantly younger at the latest visit (P = 0.02), had a higher proportion of treatment changes during five years (P = 0.002), and had a higher proportion of interleukin-6 receptor inhibitors use in 2023 (P = 0.04) than those in patients with persistent D2T RA or those who died. D2T RA resolved in 38% of patients with multidrug resistance, mainly with treatment changes. Rheumatic disease comorbidity index and glucocorticoid dose escalation were independent risk factors for mortality [odds ratio (OR), 3.50; P = 0.02 and OR, 31.9; P = 0.002, respectively].Conclusion Further modifications in RA treatment are useful for resolving D2T RA. Multiple comorbidities and glucocorticoid use are associated with mortality.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Five-year follow-up of organ retransplantation
    Belger, MA
    RETRANSPLANTATION, 1997, 29 : 15 - 16
  • [32] PROFILING OF CIRCULATING MIRNAS IN DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS
    Baloun, J.
    Pekacova, A.
    Mann, H.
    Vencovsky, J.
    Pavelka, K.
    Senolt, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 477 - 477
  • [33] Gut dysbiosis is associated with difficult-to-treat rheumatoid arthritis
    Ruiz-Limon, Patricia
    Mena-Vazquez, Natalia
    Moreno-Indias, Isabel
    Lisbona-Montanez, Jose Manuel
    Mucientes, Arkaitz
    Manrique-Arija, Sara
    Redondo-Rodriguez, Rocio
    Cano-Garcia, Laura
    Tinahones, Francisco J.
    Fernandez-Nebro, Antonio
    FRONTIERS IN MEDICINE, 2025, 11
  • [34] Five-Year Follow-Up of Peripartum Cardiomyopathy
    Namdari, M.
    Ghafarzadeh, M.
    Baharvand, B.
    IRANIAN HEART JOURNAL, 2008, 9 (01): : 18 - 21
  • [35] A Five-year Follow-up of Goucher Graduates
    McCurley, Mary T.
    VOCATIONAL GUIDANCE MAGAZINE, 1932, 10 (06): : 243 - 249
  • [36] Diogenes Syndrome: a five-year follow-up
    Greve, Kevin W.
    Curtis, Kelly L.
    Bianchini, Kevin J.
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2007, 22 (11) : 1166 - 1167
  • [37] Correspondence on: 'EULAR definition of difficult-to-treat rheumatoid arthritis'
    Novella-Navarro, Marta
    Plasencia-Rodriguez, Chamaida
    Tornero, Carolina
    Navarro-Compan, Victoria
    Cabrera-Alarcon, Jose Luis
    Peiteado, Diana
    Nuno, Laura
    Monjo, Irene
    Franco-Gomez, Karen
    Villalba, Alejandro
    Balsa, Alejandro
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (03)
  • [38] Characterizing molecular targets in difficult-to-treat rheumatoid arthritis
    Smith, Melanie H.
    Bai, Zilong
    Lakhanpal, Amit
    Ramirez, Daniel
    Dicarlo, Edward
    Donlin, Laura
    Orange, Dana
    Goodman, Susan M.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2025, 70
  • [39] The potential role of fatigue in difficult-to-treat rheumatoid arthritis
    Leon, Leticia
    Freites-Nunez, Dalifer
    Madrid, Alfredo
    Rodriguez-Mariblanca, Maria
    Fernandez-Gutierrez, Benjamin
    Abasolo, Lydia
    BMC RHEUMATOLOGY, 2024, 8 (01)
  • [40] Difficult-to-Treat Rheumatoid Arthritis in Older Adults: Implications of Ageing for Managing Patients
    Novella-Navarro, Marta
    Balsa, Alejandro
    DRUGS & AGING, 2022, 39 (11) : 841 - 849